Plain-English translation of NCT07059377 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether —a medication commonly used to help manage type 2 diabetes—can help people quit smoking. The medication works by reducing cravings and the brain's reward response to nicotine, while also helping prevent weight gain that often happens after people quit. Researchers want to see if combining this medication with therapy (like patches or gum) works better than therapy alone.
Smoking and diabetes are major risk factors for heart disease, and people with both conditions face serious health complications. While this medication is well-known for managing blood sugar and weight, early research suggests it may also help reduce nicotine cravings by affecting how the brain responds to smoking. This trial will help determine if this medication could be a new tool to help people quit smoking.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the medication plus therapy, or therapy alone for up to 6 months. You will take the medication as prescribed and use products (like patches or gum) to help manage cravings. You'll attend follow-up visits where the study team will check on your progress, ask about your smoking status, and monitor your health and blood sugar levels throughout the 6-month period.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Canada